Skip to content

Advanced Robotic Training With Additional Degrees of Freedom: Towards a Free-walking System

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02189551
Acronym
LOKOMAT
Enrollment
9
Registered
2014-07-14
Start date
2014-06-30
Completion date
2015-02-28
Last updated
2018-08-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post Stroke Gait Training

Brief summary

The objective of the study is to compare a new medical devices with an established medical device for lower limb rehabilitation regarding training outcome and patient comfort / patient satisfaction (primary objective) and treatment effect (exploratory objective). Primary study endpoints will be a significantly higher rated patient comfort and or patient satisfaction using the new versions, compared with the established Lokomat. Furthermore, muscle activity and kinematic movement patterns will be expected to show more involved muscle groups and a walking pattern involving more degrees of freedom during use of the new version compared with the established Lokomat. Exploratory endpoints will be a significantly stronger involvement of muscles needed for balance, more physiological walking patterns and more change on the lateral positioning of the feet due to training with the new version, compared with the established Lokomat.

Interventions

BEHAVIORALGait training with Lokomat Pro
BEHAVIORALGait training with Lokomat Pro FreeD

Sponsors

Swiss Commission for Technology and Innovation
CollaboratorOTHER
Swiss Federal Institute of Technology
CollaboratorOTHER
Hocoma AG
CollaboratorUNKNOWN
University of Zurich
CollaboratorOTHER
Cereneo AG
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Lower extremity weakness due to stroke * minor functional impairment (MRC \< 5) * ability and willingness to participate

Exclusion criteria

* severe spasticity of the lower extremities * severe dementia * severe depression * any other contraindications against Lokomat training * body weight \> 135 kg

Design outcomes

Primary

MeasureTime frameDescription
Lateral hip movement30 min training during day 1 (next session after inclusion)during 30 min training with each device, lateral hip movements will be assessed

Secondary

MeasureTime frameDescription
Patient satisfactionday 2 and 3Satisfaction, based on questionnaires, will be assessed after training with the experimental and the standard device in two consecutive sessions (randomized order).
Patient motivationday 2 and 3Patient motivation, based on questionnaires, will be assessed after training with the experimental and the standard device in two consecutive sessions (randomized order).

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026